Operational Flow · AI MedTech / SaMD

Operational Flow for AI MedTech / SaMD.

This page describes the operating route from source text to practical use. It maps handoffs, gates, failure points, and review moments so the work can move without losing traceability.

Source basis: AI/ML-enabled device software, SaMD, and change-control guidanceUse: evidence-readinessBoundary: not legal advice
AI MedTech / SaM TRACE FDA AI/ML SAMD HUBFDA PCCP GUIDANCFDA LIFECYCLE-MAFDA AI-ENABLED D
/ Operational route

The flow moves from source to reviewable work.

AI MedTech / SaMD
Flow

Recommended operating sequence.

Define intended medical purpose · Map device software function · Assess risk and pathway · Build data/performance evidence · Plan PCCP if applicable · Prepare transparency material · Monitor post-market signals

07
/ Failure points

Where teams usually lose traceability.

audit watch
Risk 01

Source skipped

Using a blog summary instead of the official source creates weak claims.

Risk 02

Role unclear

Provider, deployer, sponsor, manufacturer, vendor, or owner responsibilities blur.

Risk 03

Evidence not owned

A document exists but nobody owns review, update, or closure.

Risk 04

Change not logged

Model, system, SOP, source, or guidance changes do not reach the evidence file.